Kono M, Saitoh Y, Kasai M, Sato A, Shirahata K, Morimoto M, Ashizawa T
Chem Pharm Bull (Tokyo). 1989 Apr;37(4):1128-30. doi: 10.1248/cpb.37.1128.
Introducing the mercaptoethyl group at the 7-N position of mitomycin C 1 has led to the isolation of 7-N,7'-N'-dithiodiethylenedimitomycin C 2. The compound 2 showed excellent antitumor activity against sarcoma 180 (sc-ip) and leukemia P388 (ip-ip) in mice. As an extension of this study, we synthesized mitomycin dimers with symmetrical disulfide and mitomycin derivatives with unsymmetrical disulfide at the 7-N side chain. Among these compounds, the water soluble conjugate 3 with ethyl gamma-L-glutamyl-L-cysteinylglycinate was far more effective against sarcoma 180 and leukemia P388 than 1. During the subsequent stage of inquiry for the potent congeners of 3, the compound 4 (water solubility: greater than 500 mg/ml), designated as KW2149, with the gamma-L-glutamylcystamino group at the 7th position was finally selected for further evaluation.
在丝裂霉素C 1的7-N位引入巯基乙基,已导致7-N,7'-N'-二硫代二亚乙基丝裂霉素C 2的分离。化合物2对小鼠肉瘤180(皮下注射-腹腔注射)和白血病P388(腹腔注射-腹腔注射)显示出优异的抗肿瘤活性。作为本研究的延伸,我们合成了在7-N侧链带有对称二硫键的丝裂霉素二聚体以及带有不对称二硫键的丝裂霉素衍生物。在这些化合物中,与γ-L-谷氨酰-L-半胱氨酰甘氨酸乙酯形成的水溶性缀合物3对肉瘤180和白血病P388的疗效远比1有效。在随后探寻3的强效类似物的阶段,最终选择了在第7位带有γ-L-谷氨酰半胱氨基团的化合物4(水溶性:大于500 mg/ml),命名为KW2149,用于进一步评估。